Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Fatty liver therapeutic drug

A fatty liver and drug technology, applied in the field of drugs for the treatment of fatty liver, can solve the problems of extrusion damage, unsatisfactory drug effect, inconvenient use, etc.

Inactive Publication Date: 2004-08-18
张永 +1
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are oral liquids made by L-carnitine at present, but there are many defects in the existing oral liquids: mainly being inconvenient to carry, easy to be squeezed and damaged, and inconvenient to use; Drugs with carnitine as the main ingredient are less effective

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] 1, a kind of medicine for the treatment of fatty liver (all by weight):

[0022] L-carnitine 20%, mannitol 80%. The L-carnitine is taken, pulverized to a particle size of 80-100 meshes, mixed evenly with the matrix, and the above-mentioned medicine is granulated and compressed into tablets.

[0023] 2, a kind of medicine for the treatment of fatty liver (all by weight):

[0024] L-carnitine 90%, mannitol 10%. The L-carnitine is taken, pulverized to a particle size of 80-100 meshes, mixed evenly with the matrix, and the above-mentioned medicine is granulated and compressed into tablets.

[0025] 3. A medicine for the treatment of fatty liver (both by weight):

[0026] L-carnitine 50%, mannitol 50%. The L-carnitine is taken, pulverized to a particle size of 80-100 meshes, mixed evenly with the matrix, and the above-mentioned medicine is granulated and compressed into tablets.

[0027] 4. A medicine for the treatment of fatty liver (all by weight):

[0028] L-carniti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to fatty liver treating medicine, and is especially one kind of Western medicine preparation with levocarnitine as main component. The medicine preparation consists of levocarnitine in 20-100 wt% and mannitol in 0-80 wt% as matrix, and is prepared through crushing levocarnitine, mixing levocarnitine with the matrix, pelletizing and preparing into tablet or capsule. The medicine preparation is easy to absorb, fast in acting and obvious in treating effect, and is used in treating fatty liver, slimming, cardiac and cerebral vascular diseases, etc.

Description

Technical field [0001] The invention relates to a medicine for treating fatty liver, in particular to a western medicine preparation whose main active ingredient is L-carnitine. technical background [0002] L-carnitine is an effective drug for treating fatty liver, cardiovascular and cerebrovascular diseases, and losing weight. There are oral liquids made by L-carnitine at present, but there are many defects in the existing oral liquids: mainly being inconvenient to carry, easy to be squeezed and damaged, and inconvenient to use; Drugs with carnitine as the main ingredient are less effective. Contents of the invention [0003] In view of the above-mentioned shortcomings in the prior art, the object of the present invention is to provide a medicine that is easy to carry and use, and has obvious effects in treating fatty liver, losing weight, and treating cardiovascular and cerebrovascular diseases. [0004] The solution of the present invention is based on the understand...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/205A61P1/16
Inventor 张永王美岭
Owner 张永
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com